Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Operations

v3.10.0.1
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Condensed Consolidated Statements Of Operations [Abstract]    
Net revenues $ 6,371,809 $ 2,586,613
Cost of sales 1,727,729 1,272,992
Gross profit 4,644,080 1,313,621
Operating expenses:    
Research and development 2,361,823 1,958,367
Selling, general and administrative 3,293,984 3,027,698
Loss on settlement of accounts receivable   3,764,137
Total operating expenses 5,655,807 8,750,202
Operating loss (1,011,727) (7,436,581)
Non-operating (expenses) income:    
Interest expense (1,278,423)  
Other income (expense), net 26,394 (13,169)
Change in fair value of derivative liabilities 225,000  
Foreign currency transaction loss (17,544) (53,455)
Total non-operating expenses (1,044,573) (66,624)
Loss before income taxes (2,056,300) (7,503,205)
Income tax expense (benefit) 92,498 (3,246,053)
Net loss $ (2,148,798) $ (4,257,152)
Net loss per basic and diluted common share outstanding $ (0.03) $ (0.08)
Basic and diluted weighted average common shares outstanding 62,553,791 53,154,076